RNS Number : 8845O
McBride PLC
04 October 2019
 

RNS Announcement

 

 

Notification and public disclosure of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and their persons closely associated ("PCA").

 

 

4 October 2019

 

 

On 3 October 2019 McBride plc (the Company) was notified that, following the termination of an investment management agreement with a controlled undertaking, Teleios Capital Partners LLC has a holding of 42,240,914 ordinary shares of 10 pence each.

 

This announcement and the following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation.

 

1.

Details of the Persons Discharging Managerial Responsibilities ("PDMR")/Relevant Employees/Person Closely Associated ("PCA")

a)

Name

 

Teleios Capital Partners LLC

2.

Reason for the notification

b)

Position/Status

 

PCA of Igor Kuzniar, Non Executive Director

 

c)

Initial notification/amendment

 

 

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

McBride plc

b)

LEI

213800HX7FMPA2CIEF02

4.

Details of the transaction(s)

Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary shares of 10p each

 

 

GB0005746358

 

 

 

b)

Nature of the transaction

 

Termination of an investment management agreement with a controlled undertaking.

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

0.00

 

8934731

d)

Aggregated information

Aggregated volume

Price

 

N/A - Single transaction

e)

Date of the transaction

 

1 October 2019

 

f)

Place of transaction

 

Outside a trading venue.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZMMGGKDVGLZM